Trxade Group Inc (MEDS) - Total Liabilities

Latest as of June 2024: $3.06 Million USD

Based on the latest financial reports, Trxade Group Inc (MEDS) has total liabilities worth $3.06 Million USD as of June 2024. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Trxade Group Inc - Total Liabilities Trend (2006–2023)

This chart illustrates how Trxade Group Inc's total liabilities have evolved over time, based on quarterly financial data. Explore MEDS long-term asset investment ratio to see how much of total assets are deployed in long-term investments.

Trxade Group Inc Competitors by Total Liabilities

The table below lists competitors of Trxade Group Inc ranked by their total liabilities.

Company Country Total Liabilities
DecideAct A/S
CO:ACT
Denmark Dkr16.53 Million
Sino Hua-An International Bhd
KLSE:2739
Malaysia RM52.87 Million
Sherborne Investors Guernsey C Ltd
LSE:SIGC
UK GBX83.33K
Mobi724 Global Solutions Inc
V:MOS
Canada CA$15.11 Million
M N C Wireless Bhd
KLSE:0103
Malaysia RM8.80 Million
VR Resources Ltd
V:VRR
Canada CA$193.34K
Biophytis S.A.
PA:ALBPS
France €14.44 Million

Liability Composition Analysis (2006–2023)

This chart breaks down Trxade Group Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see MEDS asset base.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 4.16 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.26 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.21 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Trxade Group Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Trxade Group Inc (2006–2023)

The table below shows the annual total liabilities of Trxade Group Inc from 2006 to 2023.

Year Total Liabilities Change
2023-12-31 $11.99 Million +256.10%
2022-12-31 $3.37 Million +68.70%
2021-12-31 $2.00 Million +79.25%
2020-12-31 $1.11 Million -22.20%
2019-12-31 $1.43 Million +3.50%
2018-12-31 $1.38 Million +48.80%
2017-12-31 $929.41K -37.42%
2016-12-31 $1.49 Million -15.65%
2015-12-31 $1.76 Million +217.99%
2014-12-31 $553.68K +102.81%
2013-12-31 $273.00K +169.78%
2012-12-31 $101.19K -99.79%
2008-12-31 $48.70 Million +239975.92%
2007-12-31 $20.28K +479.54%
2006-12-31 $3.50K --

About Trxade Group Inc

NASDAQ:MEDS USA Pharmaceutical Retailers
Market Cap
$2.40 Million
Market Cap Rank
#29863 Global
#6059 in USA
Share Price
$1.37
Change (1 day)
-5.52%
52-Week Range
$1.37 - $1.45
All Time High
$67.12
About

TRxADE HEALTH, Inc. operates as health services IT company. It offers an online web-based buying and selling platform for licensed pharmaceutical wholesalers to sell brand, generic, and non-drug products and services to government organizations, hospitals, clinics and independent pharmacies. TRxADE HEALTH, Inc. is headquartered in Tampa, Florida.